Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Relpax

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Introduction Les trichoepitheliomes multiples familiaux sont des tumeurs epitheliales benignes, transmises selon le mode… Expand
Is this relevant?
2012
2012
1. In comparing the effectiveness and duration of response of different triptans in reducing the severity and duration of… Expand
Is this relevant?
2011
2011
The development of a second-generation process for the synthesis of eletriptan via a Fischer indole cyclisation is described. The… Expand
Is this relevant?
Review
2006
Review
2006
Eletriptan (Relpax) is an orally administered, lipophilic, highly selective serotonin 5-HT(1B/1D) receptor agonist ('triptan… Expand
  • figure 1
  • table I
  • table II
  • table III
  • table IV
Is this relevant?
Review
2006
Review
2006
Eletriptan (Relpax®)2 is an orally administered, lipophilic, highly selective serotonin 5-HT1B/1D receptor agonist (‘triptan… Expand
Is this relevant?
2004
2004
 
Is this relevant?
Review
2003
Review
2003
  • Masayuki Omote
  • Nihon yakurigaku zasshi. Folia pharmacologica…
  • 2003
  • Corpus ID: 22054352
Eletriptan (Relpax) is a new anti-migraine medication commonly referred to as triptans. Eletriptan is considered to reduce… Expand
Is this relevant?
2003
2003
  • The Medical letter on drugs and therapeutics
  • 2003
  • Corpus ID: 40148093
 
Is this relevant?
Review
2001
Review
2001
Eletriptan (Relpax®, Pfizer) is one of a group of anti-migraine medications commonly referred to as ‘triptans’. It is a potent… Expand
Is this relevant?
2000
2000
Eletriptan (Relpax) is a novel 5-hydroxytryptamine (serotonin)(1D/1B) agonist currently in development for the acute treatment of… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 3
Is this relevant?